Results 271 to 280 of about 465,225 (381)

Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage.

Nicotine & Tobacco Research, 2014
L. Kośmider, A. Sobczak, Maciej Fik, Jakub Knysak, M. Zaciera, J. Kurek, M. Goniewicz   +6 more
semanticscholar   +1 more source

Effect of varenicline on major adverse liver outcomes in alcohol‐associated liver disease: An exploratory analysis

Alcohol, Clinical and Experimental Research, EarlyView.
This real‐world study assessed whether varenicline improves outcomes in patients with ALD and AUD. Using data from a large electronic health record network, 1278 matched patients were analyzed. Varenicline use was associated with reduced all‐cause mortality and hepatic encephalopathy compared with FDA‐approved AUD therapies (acamprosate or naltrexone),
Pojsakorn Danpanichkul, Yanfang Pang, Donghee Kim, Thanathip Suenghataiphorn, Donghyun Ko, Andrew F. Ibrahim, Vitchapong Prasitsumrit, Kwanjit Duangsonk, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul   +10 more
wiley   +1 more source

An Insight into pattern of tobacco use and nicotine dependence in a Hilly district of North India. [PDF]

J Family Med Prim Care
Kumar D, Sanfui B, Redhu A, Joshi H, Pathania A.   +4 more
europepmc   +1 more source

A Method for the Estimation of Nicotinic Acid in Milk

, 1941
Eric Bailey, William John Dann, G. Howard Satterfield, C. D. Grinnells   +3 more
openalex   +1 more source

Detection and identification of some metabolites of isonicotinic acid hydrazide (isoniazid) in human urine [PDF]

, 1953
William Cuthbertson, Deborah Ireland, William A. Wolff   +2 more
openalex   +1 more source

The alcohol cue‐exposure paradigm as a screening tool for alcohol use disorder medication development: A critical review

Alcohol, Clinical and Experimental Research, EarlyView.
The alcohol cue‐exposure paradigm has a long history in alcohol use disorder (AUD) research. This review examined the paradigm's utility as a screening tool for AUD medication development and offers recommendations for its refinement. In summary, while the alcohol cue‐exposure paradigm has a strong foundation in AUD pharmacotherapy research, its future
Dylan E. Kirsch, Erica N. Grodin, Lorenzo Leggio, Sherry A. McKee, Lindsay R. Meredith, Ethan H. Mereish, Robert Miranda Jr, Steven J. Nieto, Stephanie S. O'Malley, Joseph P. Schacht, Lara A. Ray   +10 more
wiley   +1 more source

Evaluating practices in the management of youth nicotine vaping in hospital-based child and youth mental health and addictions settings in Canada: protocol for a mixed-methods study. [PDF]

BMJ Open
Mahdi A, Alfadhli L, Chadi N, Etches S, Ignaszewski MJ, Panesar B, Porath A, Desclouds P, Constantakis S, Samaan Z, Hatcher S, Brouwers M, Rosic T.   +12 more
europepmc   +1 more source

Variations in alcohol craving and negative mood during a clinical trial of ibudilast for alcohol use disorder

Alcohol, Clinical and Experimental Research, EarlyView.
Neuroimmune compounds are being investigated as novel treatments for alcohol use disorder (AUD). This secondary analysis of a randomized clinical trial of ibudilast for AUD (N = 102) evaluated changes in self‐report symptom measures of craving, depression, and anxiety collected monthly over 12 weeks.
Lindsay R. Meredith, Erica N. Grodin, Craig K. Enders, Lara A. Ray   +3 more
wiley   +1 more source

Tobacco-related toxicant exposure among people with and without experience of psychosis: findings from the US Population Assessment of Tobacco and Health study. [PDF]

BMJ Open
Taylor E, McNeill A, Tattan-Birch H, Marczylo T, East K, Robson D.   +5 more
europepmc   +1 more source

THE MECHANISM OF THE REFLEX APNOEA CAUSED BY NICOTINE, ESPECIALLY ON THE SPECIES DIFFERENCE BETWEEN CAT AND RABBIT

, 1956
Koichiro Takasaki
openalex   +2 more sources